Adicet Bio Inc [NASDAQ: ACET] stock went on an upward path that rose over 2.01% on Wednesday, amounting to a one-week price decrease of less than -18.93%.
Over the last 12 months, ACET stock dropped by -75.12%. The one-year Adicet Bio Inc stock forecast points to a potential upside of 83.48. The average equity rating for ACET stock is currently 1.50, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $124.90 million, with 82.17 million shares outstanding and 67.18 million shares in the current float. Compared to the average trading volume of 1.31M shares, ACET stock reached a trading volume of 3886749 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Adicet Bio Inc [ACET]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ACET shares is $9.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ACET stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JMP Securities have made an estimate for Adicet Bio Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on June 27, 2023. The new note on the price target was released on June 27, 2023, representing the official price target for Adicet Bio Inc stock. Previously, the target price had yet another drop from $20 to $6, while JP Morgan kept a Neutral rating on ACET stock.
The Average True Range (ATR) for Adicet Bio Inc is set at 0.17 The Price to Book ratio for the last quarter was 0.39, with the Price to Cash per share for the same quarter was set at 1.94.
ACET Stock Performance Analysis:
Adicet Bio Inc [ACET] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -18.93. With this latest performance, ACET shares dropped by -35.59% in over the last four-week period, additionally plugging by 16.03% over the last 6 months – not to mention a drop of -75.12% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ACET stock in for the last two-week period is set at 29.16, with the RSI for the last a single of trading hit 24.49, and the three-weeks RSI is set at 33.31 for Adicet Bio Inc [ACET]. The present Moving Average for the last 50 days of trading for this stock 2.1854, while it was recorded at 1.6180 for the last single week of trading, and 1.9903 for the last 200 days.
Insight into Adicet Bio Inc Fundamentals:
Adicet Bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.41 and a Current Ratio set at 8.41.
ACET Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ACET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Adicet Bio Inc go to 29.10%.
Adicet Bio Inc [ACET] Institutonal Ownership Details
The top three institutional holders of ACET stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in ACET stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in ACET stock with ownership which is approximately 5.8386%.
